Daimler Truck Shares Surge After Dividend Raise, Sales Growth Outlook
By Helena Smolak
Daimler Truck shares surged after it said it expects 2024 sales to grow and raised its dividend as revenue and adjusted earnings improved in the fourth quarter.
At 0827 GMT on Friday, shares of Daimler Truck traded 12% higher at a record high of EUR42.12. The company's stock grew 42% on Friday to its peak since Daimler Truck became an independent company and listed on the stock market in December 2021.
The German trucks and buses manufacturer said that it guides for sales between 490,000 and 510,000 units for this year as it expects demand to normalize, after it posted a year-on-year decline in fourth-quarter unit sales.
It reported adjusted earnings before interest and taxes of 1.56 billion euros ($1.69 billion), compared with EUR1.03 billion the previous year. Revenue rose to EUR14.95 billion in the quarter from EUR14.78 billion the year prior.
Along with the full-year results, Daimler Truck issued bonuses of EUR7000 each to eligible employees.
Write to Helena Smolak at helena.smolak@wsj.com
(END) Dow Jones Newswires
March 01, 2024 03:44 ET (08:44 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks